- draft commission directive amending directive 98 8 ec of the european parliament and of the council to include acrolein as an active substance in annex i thereto 6 pages in english - draft commission directive amending directive 98 8 ec of the european parliament and of the council to include warfarin as an active substance in annex i thereto 7 pages in english . - draft commission directive amending directive 98 8 ec of the european parliament and of the council to include warfarin sodium as an active substance in annex i thereto 7 pages in english . - draft commission directive amending directive 98 8 ec of the european parliament and of the council to include magnesium phosphide as an active substance in annex i thereto 7 pages in english . - draft commission directive amending directive 98 8 ec of the european parliament and of the council to include aluminium phosphide as an active substance in annex i thereto 7 pages in english . - draft commission directive amending directive 98 8 ec of the european parliament and of the council to include brodifacoum as an active substance in annex i thereto 6 pages in english . - draft commission decision concerning the non-inclusion of diazinon in annex i ia or ib to directive 98 8 ec of the european parliament and of the council concerning the placing of biocidal products on the market 5 pages in english . - draft commission decision concerning the non-inclusion of certain substances in annex i ia or ib to directive 98 8 ec of the european parliament and of the council concerning the placing of biocidal products on the market 13 pages in english . the six draft commission directives include acrolein warfarin warfarin sodium aluminium phosphide magnesium phosphide and brodifacoum in the european community positive list of active substances which may be used in biocidal products. the two draft commission decisions concern a list of active substances for which the industry had initially notified their intention to submit information for their risk and efficacy assessment - and on this basis they were allowed to remain on the biocides market. however when the deadline for submission of this information arrived no dossiers were submitted. consequently these substances will not be examined under the 10-year review programme established by article 16 2 of the biocides directive 98 8 ec and a decision should now be taken to remove them from the biocides market after a 12-month phase-out period. a longer phase-out period has been set for diazinon used in flea collars to allow for their authorisation as veterinary medicinal products in accordance with the applicable eu legislation.